Seeking Alpha

Charles River Laboratories (CRL) buys WuXi PharmaTech (WX +8.7%) for $21.25/share, a 28%...

Charles River Laboratories (CRL) buys WuXi PharmaTech (WX +8.7%) for $21.25/share, a 28% premium. The roughly $1.6B deal is the largest foreign takeover of a Chinese company and will allow Charles River to expand in China, where revenue from drug-testing services is growing as much as 30% annually. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|